Inhibition of HIV-1 infection by PEHMB involves perturbation of the viral co-receptor CCR5

被引：0
|
作者：
Qian, Jin [1 ]
Thakkar, Nina [1 ]
Schlipf, Lori [1 ]
Ferguson, Mary L. [1 ]
Miller, Shendra [1 ]
Kish-Catalone, Tina [1 ]
Wigdahl, Brian [1 ]
Labib, Mohamed [1 ]
Rando, Robert [1 ]
Krebs, Fred C. [1 ]
机构：
[1] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF NEUROVIROLOGY | 2006年 / 12卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P158
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [31] Complexity in human immunodeficiency virus type 1 (HIV-1) co-receptor usage: roles of CCR3 and CCR5 in HIV-1 infection of monocyte-derived macrophages and brain microglia
    Agrawal, Lokesh
    Maxwell, Christina R.
    Peters, Paul J.
    Clapham, Paul R.
    Liu, Sue M.
    Mackay, Charles R.
    Strayer, David S.
    [J]. JOURNAL OF GENERAL VIROLOGY, 2009, 90 : 710 - 722
  • [32] Quantifying the relationship between HIV-1 susceptibility to CCR5 antagonists and virus affinity for antagonist-occupied co-receptor
    Buontempo, Peter J.
    Wojcik, Lisa
    Buontempo, Catherine A.
    Ogert, Robert A.
    Strizki, Julie M.
    Howe, John A.
    Ralston, Robert
    [J]. VIROLOGY, 2009, 395 (02) : 268 - 279
  • [33] Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 co-receptor and ligand binding function
    Howard, OMZ
    Shirakawa, AK
    Turpin, JA
    Maynard, A
    Tobin, GJ
    Carrington, M
    Oppenheim, JJ
    Dean, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) : 16228 - 16234
  • [34] Targeting CCR5 trafficking to inhibit HIV-1 infection
    Boncompain, Gaelle
    Herit, Floriane
    Tessier, Sarah
    Lescure, Aurianne
    Del Nery, Elaine
    Gestraud, Pierre
    Staropoli, Isabelle
    Fukata, Yuko
    Fukata, Masaki
    Brelot, Anne
    Niedergang, Florence
    Perez, Franck
    [J]. SCIENCE ADVANCES, 2019, 5 (10):
  • [35] Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
    Schwarze, Lea Isabell
    Glow, Dawid
    Sonntag, Tanja
    Uhde, Almut
    Fehse, Boris
    [J]. GENE THERAPY, 2021, 28 (09) : 588 - 601
  • [36] Maraviroc - a CCR5 antagonist for the treatment of HIV-1 infection
    Van Der Ryst, Elna
    [J]. FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [37] CCR5 genotype and the clinical course of HIV-1 infection
    Scribner, CL
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (09) : 780 - 780
  • [38] Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application
    Lea Isabell Schwarze
    Dawid Głów
    Tanja Sonntag
    Almut Uhde
    Boris Fehse
    [J]. Gene Therapy, 2021, 28 : 588 - 601
  • [39] Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences
    Carrington, M
    Dean, M
    Martin, MP
    O'Brien, SJ
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (10) : 1939 - 1945
  • [40] CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
    Oh, Djin-Ye
    Jessen, Heiko
    Kuecherer, Claudia
    Neumann, Konrad
    Oh, Nari
    Poggensee, Gabriele
    Bartmeyer, Barbara
    Jessen, Arne
    Pruss, Axel
    Schumann, Ralf R.
    Hamouda, Osamah
    [J]. PLOS ONE, 2008, 3 (07):
12345